Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Wang BC, Shi LL, Fu C, Zhou HX, Zhang ZJ, Ding Q, Peng G. A meta-analysis of cisplatin-based concurrent chemoradiotherapy with or without cetuximab for locoregionally advanced nasopharyngeal carcinoma. Medicine (Baltimore) 2019;98:e17486. [PMID: 31626102 PMCID: PMC6824634 DOI: 10.1097/md.0000000000017486] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open

For:	Wang BC, Shi LL, Fu C, Zhou HX, Zhang ZJ, Ding Q, Peng G. A meta-analysis of cisplatin-based concurrent chemoradiotherapy with or without cetuximab for locoregionally advanced nasopharyngeal carcinoma. Medicine (Baltimore) 2019;98:e17486. [PMID: 31626102 PMCID: PMC6824634 DOI: 10.1097/md.0000000000017486] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open

Number

Cited by Other Article(s)

Kuan EC, Wang EW, Adappa ND, Beswick DM, London NR, Su SY, Wang MB, Abuzeid WM, Alexiev B, Alt JA, Antognoni P, Alonso-Basanta M, Batra PS, Bhayani M, Bell D, Bernal-Sprekelsen M, Betz CS, Blay JY, Bleier BS, Bonilla-Velez J, Callejas C, Carrau RL, Casiano RR, Castelnuovo P, Chandra RK, Chatzinakis V, Chen SB, Chiu AG, Choby G, Chowdhury NI, Citardi MJ, Cohen MA, Dagan R, Dalfino G, Dallan I, Dassi CS, de Almeida J, Dei Tos AP, DelGaudio JM, Ebert CS, El-Sayed IH, Eloy JA, Evans JJ, Fang CH, Farrell NF, Ferrari M, Fischbein N, Folbe A, Fokkens WJ, Fox MG, Lund VJ, Gallia GL, Gardner PA, Geltzeiler M, Georgalas C, Getz AE, Govindaraj S, Gray ST, Grayson JW, Gross BA, Grube JG, Guo R, Ha PK, Halderman AA, Hanna EY, Harvey RJ, Hernandez SC, Holtzman AL, Hopkins C, Huang Z, Huang Z, Humphreys IM, Hwang PH, Iloreta AM, Ishii M, Ivan ME, Jafari A, Kennedy DW, Khan M, Kimple AJ, Kingdom TT, Knisely A, Kuo YJ, Lal D, Lamarre ED, Lan MY, Le H, Lechner M, Lee NY, Lee JK, Lee VH, Levine CG, Lin JC, Lin DT, Lobo BC, Locke T, Luong AU, Magliocca KR, Markovic SN, Matnjani G, McKean EL, Meço C, Mendenhall WM, Michel L, Na'ara S, Nicolai P, Nuss DW, Nyquist GG, Oakley GM, Omura K, Orlandi RR, Otori N, Papagiannopoulos P, Patel ZM, Pfister DG, Phan J, Psaltis AJ, Rabinowitz MR, Ramanathan M, Rimmer R, Rosen MR, Sanusi O, Sargi ZB, Schafhausen P, Schlosser RJ, Sedaghat AR, Senior BA, Shrivastava R, Sindwani R, Smith TL, Smith KA, Snyderman CH, Solares CA, Sreenath SB, Stamm A, Stölzel K, Sumer B, Surda P, Tajudeen BA, Thompson LDR, Thorp BD, Tong CCL, Tsang RK, Turner JH, Turri-Zanoni M, Udager AM, van Zele T, VanKoevering K, Welch KC, Wise SK, Witterick IJ, Won TB, Wong SN, Woodworth BA, Wormald PJ, Yao WC, Yeh CF, Zhou B, Palmer JN. International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors. Int Forum Allergy Rhinol 2024;14:149-608. [PMID: 37658764 DOI: 10.1002/alr.23262] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Accepted: 08/24/2023] [Indexed: 09/05/2023]

Abstract

BACKGROUND

Sinonasal neoplasms, whether benign and malignant, pose a significant challenge to clinicians and represent a model area for multidisciplinary collaboration in order to optimize patient care. The International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors (ICSNT) aims to summarize the best available evidence and presents 48 thematic and histopathology-based topics spanning the field.

METHODS

In accordance with prior International Consensus Statement on Allergy and Rhinology documents, ICSNT assigned each topic as an Evidence-Based Review with Recommendations, Evidence-Based Review, and Literature Review based on the level of evidence. An international group of multidisciplinary author teams were assembled for the topic reviews using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses format, and completed sections underwent a thorough and iterative consensus-building process. The final document underwent rigorous synthesis and review prior to publication.

RESULTS

The ICSNT document consists of four major sections: general principles, benign neoplasms and lesions, malignant neoplasms, and quality of life and surveillance. It covers 48 conceptual and/or histopathology-based topics relevant to sinonasal neoplasms and masses. Topics with a high level of evidence provided specific recommendations, while other areas summarized the current state of evidence. A final section highlights research opportunities and future directions, contributing to advancing knowledge and community intervention.

CONCLUSION

As an embodiment of the multidisciplinary and collaborative model of care in sinonasal neoplasms and masses, ICSNT was designed as a comprehensive, international, and multidisciplinary collaborative endeavor. Its primary objective is to summarize the existing evidence in the field of sinonasal neoplasms and masses.

Collapse

Affiliation(s)

Edward C Kuan Departments of Otolaryngology-Head and Neck Surgery and Neurological Surgery, University of California, Irvine, Orange, California, USA
Eric W Wang Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
Nithin D Adappa Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Daniel M Beswick Department of Otolaryngology-Head and Neck Surgery, University of California Los Angeles, Los Angeles, California, USA
Nyall R London Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Sinonasal and Skull Base Tumor Program, Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Shirley Y Su Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Marilene B Wang Department of Otolaryngology-Head and Neck Surgery, University of California Los Angeles, Los Angeles, California, USA
Waleed M Abuzeid Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA
Borislav Alexiev Department of Pathology, Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, Chicago, Illinois, USA
Jeremiah A Alt Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, USA
Paolo Antognoni Division of Radiation Oncology, University of Insubria, ASST Sette Laghi Hospital, Varese, Italy
Michelle Alonso-Basanta Department of Radiation Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA
Pete S Batra Department of Otorhinolaryngology-Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, USA
Mihir Bhayani Department of Otorhinolaryngology-Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, USA
Diana Bell Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, California, USA
Manuel Bernal-Sprekelsen Otorhinolaryngology Department, Surgery and Medical-Surgical Specialties Department, Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain
Christian S Betz Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Jean-Yves Blay Department of Medical Oncology, Centre Léon Bérard, UNICANCER, Université Claude Bernard Lyon I, Lyon, France
Benjamin S Bleier Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA
Juliana Bonilla-Velez Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA
Claudio Callejas Department of Otolaryngology, Pontificia Universidad Católica de Chile, Santiago, Chile Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, Ohio, USA
Ricardo L Carrau Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, Ohio, USA
Roy R Casiano Department of Otolaryngology-Head and Neck Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
Paolo Castelnuovo Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, ASST Sette Laghi Hospital, Varese, Italy
Rakesh K Chandra Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Vasileios Chatzinakis Department of Head, Neck and Skull Base Surgery, Hygeia Hospital, Athens, Greece
Simon B Chen Department of Pathology, Stanford University, Stanford, California, USA
Alexander G Chiu Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, Kansas, USA
Garret Choby Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA
Naweed I Chowdhury Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Martin J Citardi Department of Otorhinolaryngology-Head & Neck Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA
Marc A Cohen Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Roi Dagan Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, Florida, USA
Gianluca Dalfino Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, ASST Sette Laghi Hospital, Varese, Italy
Iacopo Dallan Department of Otolaryngology-Head and Neck Surgery, Pisa University Hospital, Pisa, Italy
Camila Soares Dassi São Paulo ENT Center (COF), Edmundo Vasconcelos Complex, São Paulo, Brazil
John de Almeida Department of Otolaryngology-Head and Neck Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada
Angelo P Dei Tos Section of Pathology, Department of Medicine, University of Padua, Padua, Italy
John M DelGaudio Department of Otolaryngology-Head and Neck Surgery, Emory University School of Medicine, Atlanta, Georgia, USA
Charles S Ebert Department of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Ivan H El-Sayed Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA
Jean Anderson Eloy Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA
James J Evans Department of Neurological Surgery and Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Christina H Fang Department of Otorhinolaryngology-Head and Neck Surgery, Montefiore Medical Center, The University Hospital for Albert Einstein College of Medicine, Bronx, New York, USA
Nyssa F Farrell Department of Otolaryngology-Head and Neck Surgery, Washington University in St. Louis, St. Louis, Missouri, USA
Marco Ferrari Section of Otorhinolaryngology-Head and Neck Surgery, Department of Neurosciences, University of Padua, Padua, Italy
Nancy Fischbein Department of Radiology, Stanford University, Stanford, California, USA
Adam Folbe Department of Otolaryngology-Head and Neck Surgery, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA
Wytske J Fokkens Department of Otorhinolaryngology, Amsterdam UMC, Amsterdam, The Netherlands
Meha G Fox Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA
Valerie J Lund Ear Institute, University College London, London, UK
Gary L Gallia Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Paul A Gardner Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
Mathew Geltzeiler Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon, USA
Christos Georgalas Department of Otorhinolaryngology-Head and Neck Surgery, University of Nicosia Medical School, Nicosia, Cyprus
Anne E Getz Department of Otolaryngology-Head and Neck Surgery, University of Colorado, Aurora, Colorado, USA
Satish Govindaraj Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Stacey T Gray Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA
Jessica W Grayson Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA
Bradley A Gross Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
Jordon G Grube Department of Otolaryngology-Head and Neck Surgery, Albany Medical Center, Albany, New York, USA
Ruifeng Guo Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
Patrick K Ha Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA
Ashleigh A Halderman Department of Otolaryngology-Head and Neck Surgery, The University of Texas Southwestern Medical Center, Dallas, Texas, USA
Ehab Y Hanna Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Richard J Harvey Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of South Wales, Sydney, New South Wales, Australia
Stephen C Hernandez Department of Otolaryngology-Head and Neck Surgery, LSU Health Sciences Center, New Orleans, Louisiana, USA
Adam L Holtzman Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, Florida, USA
Claire Hopkins Department of Otolaryngology-Head and Neck Surgery, Guys and St Thomas' Hospital, London, UK
Zhigang Huang Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Key Laboratory of Otolaryngology-Head and Neck Surgery, Ministry of Education, Beijing, China
Zhenxiao Huang Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Key Laboratory of Otolaryngology-Head and Neck Surgery, Ministry of Education, Beijing, China
Ian M Humphreys Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA
Peter H Hwang Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, USA
Alfred M Iloreta Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Masaru Ishii Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Michael E Ivan Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
Aria Jafari Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA
David W Kennedy Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Mohemmed Khan Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Adam J Kimple Department of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Todd T Kingdom Department of Otolaryngology-Head and Neck Surgery, University of Colorado, Aurora, Colorado, USA
Anna Knisely Department of Otolaryngology, Head and Neck Surgery, Swedish Medical Center, Seattle, Washington, USA
Ying-Ju Kuo Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan
Devyani Lal Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA
Eric D Lamarre Head and Neck Institute, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio, USA
Ming-Ying Lan Department of Otorhinolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
Hien Le Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
Matt Lechner UCL Division of Surgery and Interventional Science and UCL Cancer Institute, University College London, London, UK
Nancy Y Lee Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Jivianne K Lee Department of Head and Neck Surgery, University of California, Los Angeles David Geffen School of Medicine, Los Angeles, California, USA
Victor H Lee Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Corinna G Levine Department of Otolaryngology-Head and Neck Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
Jin-Ching Lin Department of Radiation Oncology, Changhua Christian Hospital, Changhua, Taiwan
Derrick T Lin Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA
Brian C Lobo Department of Otolaryngology-Head and Neck Surgery, University of Florida, Gainesville, Florida, USA
Tran Locke Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA
Amber U Luong Department of Otorhinolaryngology-Head & Neck Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA
Kelly R Magliocca Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
Svetomir N Markovic Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA
Gesa Matnjani Department of Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Erin L McKean Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA
Cem Meço Department of Otorhinolaryngology, Head and Neck Surgery, Ankara University Medical School, Ankara, Turkey Department of Otorhinolaryngology Head and Neck Surgery, Salzburg Paracelsus Medical University, Salzburg, Austria
William M Mendenhall Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, Florida, USA
Loren Michel Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Shorook Na'ara Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA
Piero Nicolai Section of Otorhinolaryngology-Head and Neck Surgery, Department of Neurosciences, University of Padua, Padua, Italy
Daniel W Nuss Department of Otolaryngology-Head and Neck Surgery, LSU Health Sciences Center, New Orleans, Louisiana, USA
Gurston G Nyquist Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Gretchen M Oakley Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, USA
Kazuhiro Omura Department of Otorhinolaryngology, The Jikei University School of Medicine, Tokyo, Japan
Richard R Orlandi Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, USA
Nobuyoshi Otori Department of Otorhinolaryngology, The Jikei University School of Medicine, Tokyo, Japan
Peter Papagiannopoulos Department of Otorhinolaryngology-Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, USA
Zara M Patel Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, USA
David G Pfister Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Jack Phan Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Alkis J Psaltis Department of Otolaryngology-Head and Neck Surgery, Queen Elizabeth Hospital, Adelaide, South Australia, Australia
Mindy R Rabinowitz Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Murugappan Ramanathan Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Ryan Rimmer Department of Otolaryngology-Head and Neck Surgery, Yale University, New Haven, Connecticut, USA
Marc R Rosen Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Olabisi Sanusi Department of Neurosurgery, Oregon Health and Science University, Portland, Oregon, USA
Zoukaa B Sargi Department of Otolaryngology-Head and Neck Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
Philippe Schafhausen Department of Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Rodney J Schlosser Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA
Ahmad R Sedaghat Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Brent A Senior Department of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Raj Shrivastava Department of Neurosurgery and Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Raj Sindwani Head and Neck Institute, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio, USA
Timothy L Smith Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon, USA
Kristine A Smith Department of Otolaryngology-Head and Neck Surgery, University of Manitoba, Winnipeg, Manitoba, Canada
Carl H Snyderman Departments of Otolaryngology-Head and Neck Surgery and Neurological Surgery, University of California, Irvine, Orange, California, USA
C Arturo Solares Department of Otolaryngology-Head and Neck Surgery, Emory University School of Medicine, Atlanta, Georgia, USA
Satyan B Sreenath Department of Otolaryngology-Head and Neck Surgery, Indiana University, Indianapolis, Indiana, USA
Aldo Stamm São Paulo ENT Center (COF), Edmundo Vasconcelos Complex, São Paulo, Brazil
Katharina Stölzel Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Baran Sumer Department of Otolaryngology-Head and Neck Surgery, The University of Texas Southwestern Medical Center, Dallas, Texas, USA
Pavol Surda Department of Otolaryngology-Head and Neck Surgery, Guys and St Thomas' Hospital, London, UK
Bobby A Tajudeen Department of Otorhinolaryngology-Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, USA
Lester D R Thompson Head and Neck Pathology Consultations, Woodland Hills, California, USA
Brian D Thorp Department of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Charles C L Tong Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Raymond K Tsang Department of Otolaryngology-Head and Neck Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Justin H Turner Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Mario Turri-Zanoni Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, ASST Sette Laghi Hospital, Varese, Italy
Aaron M Udager Department of Pathology, Michigan Center for Translational Pathology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA
Thibaut van Zele Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium
Kyle VanKoevering Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, Ohio, USA
Kevin C Welch Department of Otolaryngology-Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
Sarah K Wise Department of Otolaryngology-Head and Neck Surgery, Emory University School of Medicine, Atlanta, Georgia, USA
Ian J Witterick Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
Tae-Bin Won Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea
Stephanie N Wong Division of Otorhinolaryngology, Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Bradford A Woodworth Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA
Peter-John Wormald Department of Otolaryngology-Head and Neck Surgery, Queen Elizabeth Hospital, Adelaide, South Australia, Australia
William C Yao Department of Otorhinolaryngology-Head & Neck Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA
Chien-Fu Yeh Department of Otorhinolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
Bing Zhou Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Key Laboratory of Otolaryngology-Head and Neck Surgery, Ministry of Education, Beijing, China
James N Palmer Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Collapse

SEOM-TTCC clinical guideline in nasopharynx cancer (2021). Clin Transl Oncol 2022;24:670-680. [PMID: 35303267 PMCID: PMC8986714 DOI: 10.1007/s12094-022-02814-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/21/2022] [Indexed: 12/08/2022]

Ueda Y, Enokida T, Okano S, Fujisawa T, Ito K, Tahara M. Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma. Front Oncol 2020;10:571304. [PMID: 33117701 PMCID: PMC7575747 DOI: 10.3389/fonc.2020.571304] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2020] [Accepted: 09/01/2020] [Indexed: 01/14/2023] Open

Abstract

Background: Platinum-containing doublet chemotherapy regimens are generally considered the standard first-line systemic therapy for recurrent or metastatic (R/M) nasopharyngeal cancer (NPC). Gemcitabine (GEM) plus cisplatin (CDDP) has become a standard therapy based on a phase 3 study in several countries, yet this regimen sometimes affects quality of life due to nausea or appetite loss. Here, we present the manageable toxicity and promising activity of paclitaxel + carboplatin + cetuximab (PCE) therapy for R/M NPC. Materials and Methods: We conducted a retrospective review of patients with R/M NPC who were treated with PCE from 2013 to 2019 at the National Cancer Center East, Kashiwa, Japan. PCE consisted of PTX 100 mg/m2 on days 1 and 8; CBDCA area under the blood concentration-time curve (AUC) 2.5 on days 1 and 8, repeated every 3 weeks; and cetuximab at an initial dose of 400 mg/m2, followed by 250 mg/m2 weekly, as reported in the paper. Results: Fourteen patients were identified, consisting of 10 males and 4 females with a median age 59.6 years (range, 43-74). Among the 12 of 14 patients assessed for efficacy, overall response rate was 58.3%, with 2 complete responses and 5 partial responses. On median follow-up of 23.8 months, median overall survival was not reached with observed death events of 2. Median PFS was 4.1 months (95% CI, 2.6-5.6 months). Two patients experienced disease progression during cetuximab maintenance and restarted PCE treatment, then achieved partial response again. The most common grade 3 or 4 adverse events were neutropenia (21.4%) and skin reaction (14.3%). No treatment-related death was observed. Conclusion: Although the number of study population was small, our results suggest that PCE is feasible and potentially effective for R/M NPC, with a 58.3% response rate and 4.1-month PFS. Further prospective evaluation is warranted.

Collapse